EGFR and KRAS Mutations in Patients With Adenocarcinoma of the Lung
Tae Won Jang, Chul Ho Oak, Hee Kyung Chang, Soon Jung Suo, Mann Hong Jung
Korean J Intern Med. 2009;24(1):48-54.   Published online 2009 Mar 6     DOI: https://doi.org/10.3904/kjim.2009.24.1.48
Citations to this article as recorded by Crossref logo
Prediction of EGFR mutations by conventional CT-features in advanced pulmonary adenocarcinoma
Yanqing Chen, Yang Yang, Longbai Ma, Huiyuan Zhu, Tienan Feng, Sen Jiang, Youyong Wei, Tingting Wang, Xiwen Sun
European Journal of Radiology.2019; 112: 44.     CrossRef
The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea
Hope S. Rugo, Jack A. Di Palma, Debu Tripathy, Richard Bryce, Susan Moran, Elizabeth Olek, Linda Bosserman
Breast Cancer Research and Treatment.2019;[Epub]     CrossRef
Diethylnitrosamine induces lung adenocarcinoma in FVB/N mouse
Zsolt Mervai, Krisztina Egedi, Ilona Kovalszky, Kornélia Baghy
BMC Cancer.2018;[Epub]     CrossRef
Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
Yong Won Choi, Jin-Hyuk Choi
The Korean Journal of Internal Medicine.2017; 32(3): 422.     CrossRef
Coexistence of an <i>EGFR</i> Mutation and an <i>ALK</i> Rearrangement in a Patient with Lung Adenocarcinoma: a Case Report
Min Ah Kim, Jin-Hyoung Kang, In-Ho Kim, Tae-Jung Kim, Seung Joon Kim, Sook Whan Sung, Sol Mi Huo
The Korean Journal of Medicine.2016; 90(1): 72.     CrossRef
Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma
Eun Young Kim, Eun Na Cho, Heae Surng Park, Arum Kim, Ji Young Hong, Seri Lim, Jong Pil Youn, Seung Yong Hwang, Yoon Soo Chang
BMC Cancer.2016;[Epub]     CrossRef
CUSTOM-SEQ: a prototype for oncology rapid learning in a comprehensive EHR environment
Jeremy L Warner, Lucy Wang, William Pao, Jeffrey A Sosman, Ravi V Atreya, Pam Carney, Mia A Levy
Journal of the American Medical Informatics Associ.2016; 23(4): 692.     CrossRef
Epidemiology of Lung Cancer in Korea: Recent Trends
Ji Young Park, Seung Hun Jang
Tuberculosis and Respiratory Diseases.2016; 79(2): 58.     CrossRef
Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers
Aaron M. Chapman, Kathie Y. Sun, Peter Ruestow, Dallas M. Cowan, Amy K. Madl
Lung Cancer.2016; 102: 122.     CrossRef
EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non–Small Cell Lung Cancer Patients
Yong Won Choi, So Yeon Jeon, Geum Sook Jeong, Hyun Woo Lee, Seong Hyun Jeong, Seok Yun Kang, Joon Seong Park, Jin-Hyuk Choi, Young Wha Koh, Jae Ho Han, Seung Soo Sheen
American Journal of Clinical Oncology.2016; : 1.     CrossRef
Bronchial-pulmonary adenocarcinoma subtyping relates with different molecular pathways
Vítor Sousa, Bruno Bastos, Maria Silva, Ana Maria Alarcão, Lina Carvalho
Revista Portuguesa de Pneumologia (English Edition.2015; 21(5): 259.     CrossRef
Pharmacogenomics and targeted therapy of cancer: Focusing on non-small cell lung cancer
Seyyed Mortaza Haghgoo, Abdolamir Allameh, Esmaeil Mortaz, Johan Garssen, Gert Folkerts, Peter J. Barnes, Ian M. Adcock
European Journal of Pharmacology.2015; 754: 82.     CrossRef
Molecular Spectrum of Somatic EGFR and KRAS Gene Mutations in non Small Cell Lung Carcinoma: Determination of Frequency, Distribution Pattern and Identification of Novel Variations in Indian Patients
Bibhu Ranjan Das, Sangeet Bhaumik, Firoz Ahmad, Aziz Mandsaurwala, Heena Satam
Pathology & Oncology Research.2015; 21(3): 675.     CrossRef
The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer
Sunny Guin, Dan Theodorescu
Acta Pharmacologica Sinica.2015; 36(3): 291.     CrossRef
Survival Benefit of Pemetrexed in Lung Adenocarcinoma Patients With Anaplastic Lymphoma Kinase Gene Rearrangements
Sojung Park, Tai Sun Park, Chang-Min Choi, Dae Ho Lee, Sang-We Kim, Jung-Shin Lee, Woo Sung Kim, Joon Seon Song, Jae Cheol Lee
Clinical Lung Cancer.2015; 16(5): e83.     CrossRef
Analysis of an EGFR mutation by PNA clamping method in lung carcinoid tumors
Jong In Kim
Kosin Medical Journal.2015; 30(2): 141.     CrossRef
KRAS oncogene substitutions in Korean NSCLC patients: Clinical implication and relationship with pAKT and RalGTPases expression
Eun Young Kim, Arum Kim, Se Kyu Kim, Hyung Jung Kim, Joon Chang, Chul Min Ahn, Jae Seok Lee, Hyo Sup Shim, Yoon Soo Chang
Lung Cancer.2014; 85(2): 299.     CrossRef
Correlation Between EGFR Mutation Status and Computed Tomography Features in Patients With Advanced Pulmonary Adenocarcinoma
Jui-Sheng Hsu, Ming-Shyan Huang, Chiao-Yun Chen, Gin-Chung Liu, Ta-Chih Liu, Inn-Wen Chong, Shah-Hwa Chou, Chih-Jen Yang
Journal of Thoracic Imaging.2014; 29(6): 357.     CrossRef
WITHDRAWN: Bronchial-pulmonary adenocarcinoma subtyping relates with different molecular pathways
Vítor Sousa, Bruno Bastos, Maria Silva, Ana Maria Alarcão, Lina Carvalho
Revista Portuguesa de Pneumologia.2014;[Epub]     CrossRef
Epidermal growth factor receptor and KRAS mutations in lung adenocarcinoma: A retrospective study of the Lebanese population
NAJLA FAKHRUDDIN, RAMI MAHFOUZ, FADI FARHAT, ARAFAT TFAYLI, RABAB ABDELKHALIK, MARK JABBOUR, LAMIS YEHIA, ZIYAD MAHFOUD, GHAZI ZAATARI
Oncology Reports.2014; 32(5): 2223.     CrossRef
EGFR Mutations in Surgically Resected Fresh Specimens from 697 Consecutive Chinese Patients with Non-Small Cell Lung Cancer and Their Relationships with Clinical Features
Yuanyang Lai, Zhipei Zhang, Jianzhong Li, Dong Sun, Yong'an Zhou, Tao Jiang, Yong Han, Lijun Huang, Yifang Zhu, Xiaofei Li, Xiaolong Yan
International Journal of Molecular Sciences.2013; 14(12): 24549.     CrossRef
Other signalization targets
Nicolas Girard
Targeted Oncology.2013; 8(1): 69.     CrossRef
Identification of Uncommon PIK3CA Mutations in Lung Cancer by Using Pyrosequencing
Verena Schildgen, Jessica Lüsebrink, Jan D. Appel, Christine Wübben, Walburga Engel-Riedel, Corinna Ludwig, Erich Stoelben, Oliver Schildgen, Michael Brockmann
Diagnostic Molecular Pathology.2013; 22(1): 22.     CrossRef
Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?
Seung Tae Kim, Jae Sook Sung, Uk Hyun Jo, Kyong Hwa Park, Sang Won Shin, Yeul Hong Kim
Medical Oncology.2013;[Epub]     CrossRef
CDKN2A/p16 Inactivation Mechanisms and Their Relationship to Smoke Exposure and Molecular Features in Non–Small-Cell Lung Cancer
Kit W. Tam, Wei Zhang, Junichi Soh, Victor Stastny, Min Chen, Han Sun, Kelsie Thu, Jonathan J. Rios, Chenchen Yang, Crystal N. Marconett, Suhaida. A. Selamat, Ite A. Laird-Offringa, Ayumu Taguchi, Samir Hanash, David Shames, Xiaotu Ma, Michael Q. Zhang, W
Journal of Thoracic Oncology.2013; 8(11): 1378.     CrossRef
Can Serum be Used for Analyzing the EGFR Mutation Status in Patients with Advanced Non-small Cell Lung Cancer?
Seung Tae Kim, Hae-Yun Jung, Jae Sook Sung, Uk Hyun Jo, Tomoaki Tanaka, Koichi Hagiwara, Kyong Hwa Park, Sang Won Shin, Jun Suk Kim, Yeul Hong Kim
American Journal of Clinical Oncology.2013; 36(1): 57.     CrossRef
Comparison of EGFR Signaling Pathway Somatic DNA Mutations Derived From Peripheral Blood and Corresponding Tumor Tissue of Patients with Advanced Non-Small-Cell Lung Cancer Using Liquidchip Technology
Hui Zhang, Deruo Liu, Shanqing Li, Yongqing Zheng, Xinjie Yang, Xi Li, Quan Zhang, Na Qin, Jialin Lu, Lifen Ren-Heidenreich, Huiyi Yang, Yuhua Wu, Xinyong Zhang, Jingying Nong, Yifen Sun, Shucai Zhang
The Journal of Molecular Diagnostics.2013; 15(6): 819.     CrossRef
EGFR and KRAS mutation analyses from specimens obtained by bronchoscopy and EBUS-TBNA
Yeh Rim Kang, Hye Yun Park, Kyeongman Jeon, Won-Jung Koh, Gee Young Suh, Man Pyo Chung, Hojoong Kim, O Jung Kwon, Yoon-La Choi, Joungho Han, Sang-Won Um
Thoracic Cancer.2013; 4(3): 264.     CrossRef
Clinical Relevance of EGFR Mutations in Colorectal Cancer Patients
Bo-Young Oh, Ryung-Ah Lee, Soon-Sup Chung, Kwang Ho Kim
The Ewha Medical Journal.2013; 36(1): 51.     CrossRef
Endometrial stromal tumors: immunohistochemical and molecular analysis of potential targets of tyrosine kinase inhibitors
Ruth Sardinha, Teresa Hernández, Susana Fraile, Francesc Tresserra, August Vidal, Maria Carmén Gómez, Aurora Astudillo, Nieves Hernández, Javier Saenz de Santamaría, Jaume Ordi, Luis Gonçalves, Rafael Ramos, Carmen Balañá, Enrique de Álava
Clinical Sarcoma Research.2013; 3(1): 3.     CrossRef
RUNX3 Downregulation in Human Lung Adenocarcinoma is Independent of p53, EGFR or KRAS Status
Mohd Feroz Mohd Omar, Kosei Ito, Min En Nga, Ross Soo, Bee Keow Peh, Tuty Muliana Ismail, Bhavin Thakkar, Richie Soong, Yoshiaki Ito, Manuel Salto-Tellez
Pathology & Oncology Research.2012; 18(4): 783.     CrossRef
Gefitinib in Selected Patients with Pre-Treated Non-Small-Cell Lung Cancer: Results from a Phase IV, Multicenter, Non-Randomized Study (SELINE)
Kwan-Ho Lee, Kye-Young Lee, Young-June Jeon, Maan-Hong Jung, Choonhee Son, Min-Ki Lee, Jeong-Seon Ryu, Sei-Hoon Yang, Jae-Cheol Lee, Young-Chul Kim, Sun-Young Kim
Tuberculosis and Respiratory Diseases.2012; 73(6): 303.     CrossRef
EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: A meta-analysis
Jing-Hua Ren, Wen-Shan He, Guo-Li Yan, Min Jin, Kun-Yu Yang, Gang Wu
Environmental and Molecular Mutagenesis.2012; 53(1): 78.     CrossRef
Primary and Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer: An Update
Ayodele Ayoola, Amit Barochia, Kiran Belani, Chandra P. Belani
Cancer Investigation.2012; 30(5): 433.     CrossRef
Driver mutations as predictive biomarkers in lung cancer
Nicolas Girard
Current Respiratory Care Reports.2012; 1(1): 21.     CrossRef
Establishment and characterization of primary lung cancer cell lines from Chinese population
Chao Zheng, Yi-hua Sun, Xiao-lei Ye, Hai-quan Chen, Hong-bin Ji
Acta Pharmacologica Sinica.2011; 32(3): 385.     CrossRef
EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung
Xiao-Li Jia, Gang Chen
Lung Cancer.2011; 74(3): 396.     CrossRef
Epidermal growth factor receptor mutation-guided treatment for lung cancers: Where are we now?
Zengliu Su
Thoracic Cancer.2011; 2(1): 1.     CrossRef
Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Seung Tae Kim, Yoon Ji Choi, Kyong Hwa Park, Sang Cheul Oh, Jae Hong Seo, Sang Won Shin, Jun Suk Kim, Yeul Hong Kim
Chemotherapy.2011; 57(2): 108.     CrossRef
Epidermal Growth Factor Receptor Mutations in Colorectal Cancer Patients
Bo-Young Oh, Ryung-Ah Lee, Soon-Sup Chung, Kwang Ho Kim
Journal of the Korean Society of Coloproctology.2011; 27(3): 127.     CrossRef
Rapid KRAS, EGFR, BRAF and PIK3CA Mutation Analysis of Fine Needle Aspirates from Non-Small-Cell Lung Cancer Using Allele-Specific qPCR
Ronald van Eijk, Jappe Licht, Melanie Schrumpf, Mehrdad Talebian Yazdi, Dina Ruano, Giusi I. Forte, Petra M. Nederlof, Maud Veselic, Klaus F. Rabe, Jouke T. Annema, Vincent Smit, Hans Morreau, Tom van Wezel, Ralf Krahe
PLoS ONE.2011; 6(3): e17791.     CrossRef
Study of the correlation of EGFR and K-RAS gene mutations with its protein expression in non-small cell lung cancer
Huan-ling Luan, Lei-na Sun, Na Dong, Yan Guo, Bao-cun Sun, Zhong-li Zhan
Clinical Oncology and Cancer Research.2010; 7(2): 97.     CrossRef
Chromosomal imbalances in lung adenocarcinomas with or without mutations in the epidermal growth factor receptor gene
Yao FONG, Yue-Shan LIN, Chiou-Ping LIOU, Chien-Fen LI, Ching-Cherng TZENG
Respirology.2010; 15(4): 700.     CrossRef
The Role of Irreversible EGFR Inhibitors in the Treatment of Non-Small Cell Lung Cancer: Overcoming Resistance to Reversible EGFR Inhibitors
Chandra P. Belani
Cancer Investigation.2010; 28(4): 413.     CrossRef
PAR-4 as a possible new target for pancreatic cancer therapy
Asfar S Azmi, Philip A Philip, Syed F Zafar, Fazlul H Sarkar, Ramzi M Mohammad
Expert Opinion on Therapeutic Targets.2010; 14(6): 611.     CrossRef
Chemotherapy for lung cancer: the state of the art in 2009
Michaela J Higgins, David S Ettinger
Expert Review of Anticancer Therapy.2009; 9(10): 1365.     CrossRef